Stocks and Investing Stocks and Investing
Thu, September 8, 2022
Wed, September 7, 2022

Francois Brisebois Initiated (AQST) at Buy and Held Target at $8.5 on, Sep 7th, 2022


Published on 2024-10-27 22:55:42 - WOPRAI, Francois Brisebois
  Print publication without navigation


Francois Brisebois of Oppenheimer, Initiated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $8.5 on, Sep 7th, 2022.

Francois has made no other calls on AQST in the last 4 months.



There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with Francois's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Francois


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, September 6th, 2022
  • James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $10 on, Tuesday, August 30th, 2022

Contributing Sources